Comorbidity in Anxiety Disorders
Comorbidity in Anxiety Disorders
复制标题
DOI：
10.1007/7854_2009_32
复制
发表时间：
2010-01-01
期刊：
影响因子：
--
通讯作者：
Swanson, Sonja Alsemgeest
中科院分区：
文献类型：
--
作者：
Merikangas, Kathleen Ries;Swanson, Sonja Alsemgeest
自从Feinstein创造了术语“合并症”，指的是在患有特定指标疾病的患者中存在任何额外的共存疾病（J Chronic Dis 23：455-468，1970），该现象的各个方面已经被广泛研究。本章的目的是：（1）总结成人人群中焦虑障碍的精神共病证据;（2）介绍国家共病调查重复（NCS-R）的结果;（3）总结儿童和青少年人群中焦虑障碍的精神共病证据;（4）从家族和遗传学研究中总结共病的证据;（5）检查焦虑症和医疗条件之间的共病模式。在每一个这些目标，并发症的影响进行了探讨，包括这些模式是否反映了需要重新定义的障碍，而是病因，甚至因果关系的路径。
Ever since Feinstein coined the term "comorbidity", referring to the presence of any additional coexisting ailment in a patient with a particular index disease (J Chronic Dis 23:455-468, 1970), aspects of the phenomenon have been extensively studied. The aims of this chapter are: (1) to summarize the evidence of psychiatric comorbidity in anxiety disorders from adult population-based studies; (2) to present findings from the National Comorbidity Survey Replication (NCS-R); (3) to summarize evidence of psychiatric comorbidity in anxiety disorders from child and adolescent population-based samples; (4) to provide a summary of evidence on comorbidity from family and genetic studies; and (5) to examine patterns of comorbidity between anxiety disorders and medical conditions. Throughout each of these aims, implications of the comorbidity are explored, including whether these patterns reflect a need for redefining the disorders or rather an etiologic or even causal path.